Literature DB >> 15705116

Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries.

Luis E Morillo1, Fernando Alarcon, Nayesca Aranaga, Sara Aulet, Evelina Chapman, Lucien Conterno, Edmundo Estevez, Felipe Garcia-Pedroza, Juanita Garrido, Miguel Macias-Islas, Paulo Monzillo, Lilia Nunez, Noel Plascencia, Carlos Rodriguez, Yuri Takeuchi.   

Abstract

OBJECTIVE: The objective of this study was to document the clinical characteristics of migraine and patterns of medication use in residents > or =15 years old in 12 Latin American urban communities.
BACKGROUND: Few large-scale population studies have established the symptoms and disability associated with migraine with or without aura in Latin American urban communities or the pattern of medication use in these regions.
METHODS: In this study, subjects in 12 urban communities, from 6 Latin American countries, were surveyed with a validated face-to-face interview questionnaire based on International Headache Society criteria for migraine. The questionnaire was completed during face-to-face interviews with headache sufferers within selected households and included questions about migraine symptoms, migraine-related disability, and the use of health-care resources and medications to treat migraines.
RESULTS: Of the 8618 people available for screening, 62% suffered from headaches. Of individuals with migraine, 42% reported consulting a health-care professional about their headaches. Of the migraineurs, 94.2% reported moderate to severe pain. Associated symptoms of nausea or vomiting, photophobia, phonophobia, and osmophobia were common during migraine attacks in 30.3, 76.4, 85.1, and 47.7% of subjects, respectively. The majority of subjects suffered between one and eight migraines each month. Although no previous diagnosis of migraine was reported by 65% of headache sufferers, migraineurs lost an average of 8 days in the preceding 3 months in any of the following areas: school, work, household chores, and/or social, family, or leisure activities. The agents used most widely to treat migraine were paracetamol and salicylates, while nonsteroidal anti-inflammatory drugs, dypirone, and ergotamines were also commonly used. Medication use varied widely among countries, but was predominantly nonprescription.
CONCLUSIONS: Migraine is a common disorder in Latin American urban communities imposing significant burden on individuals, families, and communities. The magnitude of the impact and the range of activities affected by migraine are similar to those of previous reports in other regions. The preponderance of nonprescription medications and the scarcity of migraine-specific triptans from the study findings are especially striking.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15705116     DOI: 10.1111/j.1526-4610.2005.05025.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  10 in total

Review 1.  Management of headache in the elderly.

Authors:  Matthew S Robbins; Richard B Lipton
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  Secular changes in health care utilization and work absence for migraine and tension-type headache: a population based study.

Authors:  A C Lyngberg; B K Rasmussen; T Jørgensen; R Jensen
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 3.  Migraine and olfactory stimuli.

Authors:  Christina Sjöstrand; Ivanka Savic; Eva Laudon-Meyer; Lena Hillert; Karin Lodin; Elisabet Waldenlind
Journal:  Curr Pain Headache Rep       Date:  2010-06

4.  Clinical features associated with ictal osmophobia in migraine.

Authors:  Filippo Baldacci; Cinzia Lucchesi; Martina Ulivi; Martina Cafalli; Marcella Vedovello; Andrea Vergallo; Eleonora Del Prete; Angelo Nuti; Ubaldo Bonuccelli; Sara Gori
Journal:  Neurol Sci       Date:  2014-07-29       Impact factor: 3.307

5.  Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference.

Authors:  Steffen Naegel; Mark Obermann
Journal:  Neuropsychiatr Dis Treat       Date:  2010-02-03       Impact factor: 2.570

6.  The Prevalence of Osmophobia in Migranous and Episodic Tension Type Headaches.

Authors:  Ahmad Chitsaz; Abbas Ghorbani; Masoumeh Dashti; Mohsen Khosravi; Mohammadreza Kianmehr
Journal:  Adv Biomed Res       Date:  2017-04-17

7.  Characteristics of migraine in patients with headache disorders: A clinic-based study from Central American and Caribbean countries.

Authors:  Priscilla Monterrey; Mónica González; Deyanira Ramírez; Fernando Gracia; Freddy Henríquez; Eka Pérez-Franco; Alejandro Díaz; Juan F Vásquez; Aarón Benzadón; Jeanine Obage; Diego Luna; Wilfran Pertuz
Journal:  Headache       Date:  2022-08-26       Impact factor: 5.311

Review 8.  From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries.

Authors:  Marta Allena; Zaza Katsarava; Giuseppe Nappi
Journal:  J Headache Pain       Date:  2009-02-24       Impact factor: 7.277

9.  Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment, and economic impact.

Authors:  Emina Sokolovic; Franz Riederer; Thomas Szucs; Reto Agosti; Peter Stefan Sándor
Journal:  J Headache Pain       Date:  2013-03-26       Impact factor: 7.277

10.  Acute migraine: Current treatment and emerging therapies.

Authors:  Arun A Kalra; Debra Elliott
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.